OVERVIEW
|
|
|
Wang T, Niu X, Gao T, Zhao L, Li J, Gan Y, Liu Y, Mao Q.
Prognostic Factors for Survival Outcome of High-Grade
Multicentric Glioma.
World Neurosurg. 2018 Jan 12. pii:
S1878-8750(18)30075-5. doi: 10.1016/j.wneu.2018.01.035. [Epub
ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
|
Yeboa DN, Rutter CE, Park HS, Lester-Coll NH, Corso CD, Mancini
BR, Bindra RS, Contessa J, Yu JB.
Patterns of care and
outcomes for use of concurrent chemoradiotherapy over radiotherapy
alone for anaplastic gliomas.
Radiother Oncol. 2017 Oct
17. pii: S0167-8140(17)32599-9. doi: 10.1016/j.radonc.2017.09.027.
[Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
NOMOGRAMS
|
|
.
|
Xia Y, Liao W, Huang S, Liu Z, Huang X, Yang C, Ye C, Jiang Y,
Wang J.
Nomograms for Predicting the Overall and
Cancer-Specific Survival of Patients With High-Grade Glioma: A
Surveillance, Epidemiology, and End Results Study.
Turk
Neurosurg. 2019 May 17. doi: 10.5137/1019-5149.JTN.26131-19.2.
[Epub ahead of print]
Source
.
Similar
articles
|
|
|
CHEMOTHERAPY
|
|
|
Xu
W, Li T, Gao L, Zheng J, Shao A, Zhang J.
Efficacy
and safety of long-term therapy for high-grade glioma with
temozolomide: a meta-analysis.
Oncotarget.
2017 Apr 24. doi: 10.18632/oncotarget.17401. [Epub ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
CLINICAL
PREDICTORS FOR SURVIVAL
|
|
|
Noiphithak
R, Veerasarn K.
Clinical
predictors for survival and treatment outcome of high-grade glioma
in Prasat Neurological Institute.
Asian
J Neurosurg. 2017 Jan-Mar;12(1):28-33. doi:
10.4103/1793-5482.148791.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
IMAGING
|
|
|
Moller
S, Law I, Munck Af Rosenschold P, Costa J, Poulsen HS, Engelholm
SA, Engelholm S.
Prognostic
value of 18F-FET
PET imaging in re-irradiation of high-grade glioma: Results of a
phase I clinical trial.
Radiother
Oncol. 2016 Oct;121(1):132-137. doi: 10.1016/j.radonc.2016.08.014.
Epub 2016 Sep 9.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
RADIOTHERAPY
|
|
|
Espinoza
JC, Haley K, Patel N, Dhall G, Gardner S, Allen J, Torkildson J,
Cornelius A, Rassekh R, Bedros A, Etzl M, Garvin J, Pradhan K,
Corbett R, Sullivan M, McGowage G, Stein D, Jasty R, Sands SA, Ji
L, Sposto R, Finlay JL.
Outcome
of young children with high-grade glioma treated with
irradiation-avoiding intensive chemotherapy regimens: Final report
of the Head Start II and III trials.
Pediatr
Blood Cancer. 2016 Jun 22. doi: 10.1002/pbc.26118. [Epub ahead of
print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
.
|
Marra JS, Mendes GP, Yoshinari GH Jr, da Silva Guimarães F,
Mazin SC, de Oliveira HF.
Survival after radiation
therapy for high-grade glioma.
Rep Pract Oncol
Radiother. 2019 Jan-Feb;24(1):35-40. doi:
10.1016/j.rpor.2018.09.003. Epub 2018 Oct 11.
Source
| Full
text |
Similar
articles
|
|
|
|
Yang
P, Zhang C, Cai J, You G, Wang Y, Qiu X, Li S, Wu C, Yao K, Li W,
Peng X, Zhang W, Jiang T.
Radiation
combined with temozolomide contraindicated for young adults
diagnosed with anaplastic glioma.
Oncotarget.
2016 Aug 31. doi: 10.18632/oncotarget.11756. [Epub ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
PERIVENTRICULAR
ZONE AND SUBVENTRICULAR ZONE
|
|
|
Valiyaveettil D, Malik M, Joseph DM.
Effect of radiation
dose to the periventricular zone and subventricular zone on
survival in anaplastic gliomas.
Ecancermedicalscience.
2019 Jul 31;13:956. doi: 10.3332/ecancer.2019.956.
Source
.
Similar
articles
|
|
|
SURGERY
|
|
|
Kawaguchi
T, Sonoda Y, Shibahara I, Saito R, Kanamori M, Kumabe T, Tominaga
T.
Impact
of gross total resection in patients with WHO grade III glioma
harboring the IDH 1/2 mutation without the 1p/19q co-deletion. J
Neurooncol. 2016 Jul 11. [Epub ahead of print]
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
Recurrent
tumors
|
|
|
|
CHEMOTHERAPY
|
|
|
Zhou
X, Liao X, Zhang B, He H, Shui Y, Xu W, Jiang C, Shen L, Wei Q.
Recurrence
patterns in patients with high-grade glioma following
temozolomide-based chemoradiotherapy.
Mol
Clin Oncol. 2016 Aug;5(2):289-294. Epub 2016 Jun 15.
Source
|
Abstract
|
Full
text |
Similar
articles
|
|
|
RADIOTHERAPY
|
|
|
|
RE-IRRADIATION
|
|
.
|
Attal J, Chaltiel L, Lubrano V, Sol JC, Lanaspeze C, Vieillevigne
L, Latorzeff I, Cohen-Jonathan Moyal E.
Subventricular
zone involvement at recurrence is a strong predictive factor of
outcome following high grade glioma reirradiation.
J
Neurooncol. 2018 Jan;136(2):413-419. doi:
10.1007/s11060-017-2669-4. Epub 2017 Dec 22.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Shanker M, Chua B, Bettington C, Foote MC, Pinkham MB.
Re-irradiation for recurrent high-grade gliomas: a
systematic review and analysis of treatment technique with respect
to survival and risk of radionecrosis.
Neurooncol Pract.
2019 Mar;6(2):144-155. doi: 10.1093/nop/npy019. Epub 2018 Jun 14.
Source
.
Similar
articles
|
|
|
SURGERY
|
|
.
|
Chun SJ, Park SH, Park CK, Kim JW, Kim TM, Choi SH, Lee ST, Kim
IH.
Survival gain with re-Op/RT for recurred high-grade
gliomas depends upon risk groups.
Radiother Oncol. 2018
Jun 21. pii: S0167-8140(18)30283-4. doi:
10.1016/j.radonc.2018.05.024. [Epub ahead of print]
Source
|
Abstract
| Full
text |
Similar
articles
|
|
|
|
|
|
|
